Hippocratic AI is the leading generative AI company in healthcare. We have the only system that can have safe, autonomous, clinical conversations with patients. We have trained our own LLMs as part of our Polaris constellation, resulting in a system with over 99.9% accuracy.
Why Join Our TeamReinvent healthcare with AI that puts safety first. We’re building the world’s first healthcare‑only, safety‑focused LLM — a breakthrough platform designed to transform patient outcomes at a global scale. This is category creation.
Work with the people shaping the future. Hippocratic AI was co‑founded by CEO Munjal Shah and a team of physicians, hospital leaders, AI pioneers, and researchers from institutions like El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, Meta, Microsoft, and NVIDIA.
Backed by the world’s leading healthcare and AI investors. We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children’s, WellSpan Health, John Doerr, Rick Klausner, and others.
Build alongside the best in healthcare and AI. Join experts who’ve spent their careers improving care, advancing science, and building world‑changing technologies — ensuring our platform is powerful, trusted, and truly transformative.
As VP, Sales – BioTech, you will own Hippocratic AI's commercial relationships with the world's largest biotech accounts. You will lead strategic enterprise sales cycles from prospect to close with the top commercial-stage biotech companies, driving the company toward its growth goal for 2027. This role sits at the intersection of enterprise sales excellence and cutting-edge healthcare AI, requiring a leader who can navigate complex, multi-stakeholder organizations while closing strategic deals at scale.
You will report to the Chief Commercial Officer and partner closely with Product, Clinical, and GTM teams to land and expand AI-driven patient engagement solutions across the biotech vertical. This is a field-first, hunter role — comfortable owning accounts from cold outreach through close. with travel expectations; 20-40% within the U.S.
What You'll DoDrive end-to-end enterprise deals with commercial-stage biotechs.
Partner with Product, Clinical, and ML teams on biotech use cases including patient support programs, specialty drug adherence, rare disease navigation, and clinical trial recruitment.
Build ROI frameworks and consultative business cases for biotech buyers using an analytical, structuring-forward approach.
Maintain pipeline discipline with accurate forecasting and strong CRM hygiene.
Represent Hippocratic AI at biotech conferences, investor days, and industry events to build executive relationships and pipeline.
This is a field-first, hunter role — comfortable owning accounts from cold outreach through close. with travel expectations; 20-40% within the U.S.
Bachelor’s degree required and advanced degree preferred.
10+ years of enterprise sales experience, with at least 5 years of experience selling to commercial-stage biotech or specialty pharma.
Demonstrated track record closing large ($500K–$2M+) enterprise deals with biotech or specialty pharma companies.
Experience selling consulting, SaaS, or AI solutions requiring creativity, stakeholder alignment, and bespoke structuring.
VP-level enterprise seller with a quota-carrying history at ~$3M ARR per year.
Strong communication skills — ability to work across technical and non-technical teams.
Commitment to safety, ethics, and patient-centered outcomes.
Intellectual curiosity and mission alignment.
Strong analytical skills; IB or management consulting background a plus for use-case depth and ROI previewing.
Existing relationships with commercial executives at commercial-stage biotechs.
Experience with digital health, AI-driven patient engagement, or specialty drug support programs.
Startup, scale-up, or regulated-industry experience in a high-growth healthcare technology company.
If you've read this and thought "that's the job I've been trying to find" — we'd like to talk.
Please be aware of recruitment scams impersonating Hippocratic AI. All recruiting communication will come from @hippocraticai.com email addresses. We will never request payment or sensitive personal information during the hiring process.
Skills Required
- Bachelor's degree
- Advanced degree
- 10+ years enterprise sales experience
- At least 5 years selling to commercial-stage biotech or specialty pharma
- Proven track record closing large ($500K-$2M+) enterprise deals with biotech or specialty pharma
- Experience selling consulting, SaaS, or AI solutions
- VP-level quota-carrying history (~$3M ARR per year)
- Strong communication skills; ability to align technical and non-technical stakeholders
- Pipeline discipline with accurate forecasting and strong CRM hygiene
- Commitment to safety, ethics, and patient-centered outcomes
- Strong analytical skills or IB/management consulting background
- Existing relationships with commercial executives at commercial-stage biotechs
- Experience with digital health, AI-driven patient engagement, or specialty drug support programs
- Startup, scale-up, or regulated-industry experience in a high-growth healthcare technology company
What We Do
Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, Microsoft, Meta and NVIDIA. Hippocratic AI has received a total of $137 million in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, SV Angel, NVentures (Nvidia Venture Capital), and Greycroft. For more information on Hippocratic AI: www.HippocraticAI.com.



.png)





